Topic Description

Treatment options for cancer often include a combination of surgery, radiation therapy and chemotherapy. Over the past decade, many new treatments and diagnostic methods for cancer have been designed. The discovery of new genes associated with cancer has led to novel, informative biomarkers. High-throughput technologies facilitate pharmacotherapeutic possibilities and patient-derived cancer cell lines can be used to learn how tumours respond to these new drugs, increasing the success rate of personalised cancer treatments. Immunotherapy has become a clinically validated treatment for many cancers. These innovations are transforming cancer diagnosis and therapy and are largely improving prognosis.


The targeted audience is the R&D community of Leiden Bio Science Park (BSP), with both its public organizations (LUMC/Hogeschool) and its ~100 biotech companies.